author-photo

Javier Briones

Autonomous University of Barcelona

170

Papers

3779

Citations

Citation Trend

Filter By

Papers (123) Sort By

Journal Conference Others

Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.

2021 Clinical And Translational Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma.

2021 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (4)
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Reference values for the EORTC QLQ-C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.

2021 European Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Brentuximab Vedotin Plus ESHAP (BRESHAP) Versus ESHAP As Salvage Strategy for Patients with Primary Refractory or Relapsed Classical Hodgkin's Lymphoma. Preliminary Results from the Breselibet Prospective Clinical Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Phase Ib study of BET inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

2021 Blood Advances
Show All
- Source
- Cite
- Save
Citations (0)
Linfoma no Hodgkin nodal de zona marginal bajo tratamiento anti-TNF en enfermedad de Crohn.

2021 Gastroenterología y Hepatología
Show All
- Source
- Cite
- Save
Citations (0)
Comorbilidades asociadas al riesgo de morir por COVID-19 en una cohorte de pacientes ingresados a un hospital de alta complejidad

2021 Medwave
Show All
- Source
- Cite
- Save
Citations (0)
A First-in-Human Study of YTB323, a Novel, Autologous CD19-Directed CAR-T Cell Therapy Manufactured Using the Novel T-Charge TM platform, for the Treatment of Patients (Pts) with Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of Ruxolitinib in steroid-refractory/dependent chronic graft-versus-host disease: Real-world Data and Challenges.

2021
Show All
- Source
- Cite
- Save
Citations (0)